Virtual event
Virtual event
Metabolomics of infectious diseases – COVID-19 and beyond
During this event you will learn
- Why metabolism is vital in the regulation of immune responses
- How lipid signatures differ depending on COVID-19 severity
- How metabolism can hint at the outcome in critically-ill patients
By entering your contact details left you agree to our Privacy policy.
Metabolomics of infectious diseases – COVID-19 and beyond
By entering your contact details left you agree to our Privacy policy.
Agenda
04:00 pm CET
Welcome & Introduction
Local or systemic effects – what drives outcome in infectious diseases?
Mag. Stefan Ledinger, BSc
Director Business Development
biocrates life sciences ag, Innsbruck, Austria
04:10 pm CET
COVID-19 infection results in alterations of the kynurenine pathway and fatty acid metabolism as a function of biological and clinical correlates
Dr. Julie A. Reisz Haines
University of Colorado Anschutz Medical Campus, Aurora, USA
04:35 pm CET
Lipidomics- and metabolomics based stratification of COVID-19 patients
Dr. Marianna Caterino
CEINGE-Biotecnologie Avanzate,
University of Naples, Italy
05:00 pm CET
Could metabolomics assist disease management in
critically-ill COVID-19 patients?
Dr. Mohamed A. Elrayess
Biomedical Research Center (BRC), Qatar University, Qatar
05:25 pm CET
Conclusion and wrap-up
Dr. Kathrine Black
Business Development Manager
biocrates inc., Laguna Hills, USA
Mag. Stefan Ledinger, BSc
Director Business Development
biocrates life sciences ag, Innsbruck, Austria
Abstracts
Abstracts will follow soon